ATE370727T1 - Pharmazeutische suspensionstabletten- zusammenstellungen - Google Patents

Pharmazeutische suspensionstabletten- zusammenstellungen

Info

Publication number
ATE370727T1
ATE370727T1 AT98959527T AT98959527T ATE370727T1 AT E370727 T1 ATE370727 T1 AT E370727T1 AT 98959527 T AT98959527 T AT 98959527T AT 98959527 T AT98959527 T AT 98959527T AT E370727 T1 ATE370727 T1 AT E370727T1
Authority
AT
Austria
Prior art keywords
percent
tablets
microcrystalline cellulose
tablet compositions
pharmaceutical suspension
Prior art date
Application number
AT98959527T
Other languages
English (en)
Inventor
Michael Augello
Sheila Dell
George Agyilirah
George Reier
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Application granted granted Critical
Publication of ATE370727T1 publication Critical patent/ATE370727T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
AT98959527T 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten- zusammenstellungen ATE370727T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/989,787 US5955107A (en) 1997-12-12 1997-12-12 Pharmaceutical suspension tablet compositions

Publications (1)

Publication Number Publication Date
ATE370727T1 true ATE370727T1 (de) 2007-09-15

Family

ID=25535456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959527T ATE370727T1 (de) 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten- zusammenstellungen

Country Status (7)

Country Link
US (1) US5955107A (de)
EP (1) EP1035838B1 (de)
AT (1) ATE370727T1 (de)
AU (1) AU1531199A (de)
DE (1) DE69838300T2 (de)
ES (1) ES2293694T3 (de)
WO (1) WO1999030689A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
ATE349203T1 (de) * 1998-06-11 2007-01-15 Pharmacia & Upjohn Co Llc Delavirdin tablettenformulierung
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
AU2001261744A1 (en) * 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
CN1688291A (zh) * 2002-02-01 2005-10-26 辉瑞产品公司 含有固体药物分散体的即刻释放剂型
CN1681497A (zh) * 2002-07-16 2005-10-12 兰贝克赛实验室有限公司 口服给药用的可分散片剂
US20070014850A1 (en) * 2002-08-02 2007-01-18 Ramalingam Manikandan Process for the preparation of dispersible tablets of cephalexin
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
WO2007095716A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
EP3064064A1 (de) * 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Verfahren und zusammensetzungen zur abschreckung vor missbrauch
CN104968333B (zh) 2012-11-30 2018-07-10 阿库拉制药公司 活性药物成分的自调节释放
EP2938347A4 (de) * 2012-12-30 2016-08-10 Hadasit Med Res Service Verwendung von alginatzusammensetzungen zur verhütung oder verminderung von leberschäden durch hepatotoxika
JP6510628B2 (ja) 2014-03-26 2019-05-15 サン・ファーマ・アドバンスト・リサーチ・カンパニー・リミテッド 乱用防止即時放出性被覆リザーバ固体剤形
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
WO2023101951A1 (en) * 2021-12-03 2023-06-08 Hercules Llc An organic chewable composition comprising certified organic ingredients, and process for preparing the same
US12605388B2 (en) 2024-09-25 2026-04-21 Azurity Pharmaceuticals Ireland Limited Lamotrigine salts, co-crystals, and compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
US4965072A (en) * 1988-11-03 1990-10-23 Miles Inc. Granulating composition and method
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
MX9704079A (es) * 1994-12-01 1997-12-31 Cibus Pharmaceutical Inc Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals

Also Published As

Publication number Publication date
DE69838300D1 (de) 2007-10-04
ES2293694T3 (es) 2008-03-16
EP1035838A1 (de) 2000-09-20
WO1999030689A1 (en) 1999-06-24
EP1035838A4 (de) 2006-01-18
EP1035838B1 (de) 2007-08-22
AU1531199A (en) 1999-07-05
US5955107A (en) 1999-09-21
DE69838300T2 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
DE69838300D1 (de) Pharmazeutische suspensionstabletten-zusammenstellungen
ES2223669T3 (es) Forma oral de dosificacion "una vez al dia" de metoprolol.
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
ATE209898T1 (de) Feste arzneizubereitung
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
FI864605A0 (fi) Terapeutiska sammansaettningar.
MY104010A (en) Pharmaceutical compositions.
CA2330480A1 (en) Controlled release formulation of divalproex sodium
RU96116411A (ru) Быстро распадающаяся готовая препаративная форма трамадола или соли трамадола
ATE391495T1 (de) Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
CA2229283A1 (en) Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease
HRP20100399T1 (hr) Oralno dezintegrirajući pripravak olanzapina ili donepezila
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
HUP9801241A2 (hu) Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra
BR0117147A (pt) preparado de dosagem oral de desintegração instantánea
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
SE8901003L (sv) Snabbloesliga preparat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties